Physician profile
Oussama Boundaoui
NPI 1053601583
$6,335.34
in general payments reported to CMS, 2019-2025
28 companies · $547 in 2025
The $547 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $304 · 2020: $329 · 2021: $1,126 · 2022: $373 · 2023: $636 · 2024: $3,020 · 2025: $547.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,292 · Food and Beverage: $1,886 · Gift: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,291.84 |
| Food and Beverage | $1,885.97 |
| Gift | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec USA, INC. | $2,375.96 | 2024 | Visumax, Cirrus Hd-Oct, Veracity Surgical |
| Abbvie INC. | $1,039.91 | 2021-2025 | Durysta |
| Regeneron Healthcare Solutions, INC. | $910.19 | 2019-2025 | Eylea Hd, Eylea |
| Allergan, INC. | $350.94 | 2020-2022 | |
| Glaukos Corporation | $215.52 | 2020-2025 | Idosetr, Istent Infinite, Istent Trabecular Micro-Bypass System Model Is3 |
| Alimera Sciences, INC. | $172.46 | 2019-2024 | Iluvien, Yutiq |
| Alcon Vision LLC | $164.04 | 2019-2025 | Clareon, Hydrus Microstent, Rocklatan |
| Biotissue Holdings INC. | $152.09 | 2019-2024 | |
| Genentech USA, INC. | $150.80 | 2022-2025 | Vabysmo |
| Bausch & Lomb Americas INC. | $104.19 | 2022-2024 | Vyzulta, Prolensa, Lotemax Sm |
| Thea Pharma INC. | $84.29 | 2022-2025 | Iyuzeh |
| Dompe US, INC. | $77.88 | 2025 | Oxervate |
| Harrow Eye, LLC | $65.59 | 2025 | Vevye |
| Novartis Pharmaceuticals Corporation | $62.43 | 2019-2022 | |
| Apellis Pharmaceuticals, INC. | $51.83 | 2023-2025 | Syfovre |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $46.37 | 2023-2024 | Izervay |
| Johnson & Johnson Surgical Vision, INC. | $38.40 | 2023-2024 | Tecnis Simplicity |
| Akorn Operating Company LLC | $38.32 | 2021 | |
| Tarsus Pharmaceuticals, INC. | $35.87 | 2024 | Xdemvy |
| Aerie Pharmaceuticals, INC. | $33.96 | 2019 | |
| Haag-Streit USA, INC. | $25.00 | 2025 | |
| Amgen INC. | $24.02 | 2025 | Tepezza |
| Rayner Intraocular Lenses Limited | $23.84 | 2024 | Rayone Aspheric, Rayone Emv, Omidria |
| Sight Sciences, INC. | $22.88 | 2025 | Sion Surgical Instrument, Omni Surgical System |
| Sun Pharmaceutical Industries INC. | $21.45 | 2025 | |
| Carl Zeiss Meditec, INC. | $17.29 | 2019 | |
| New World Medical,INC. | $16.98 | 2023-2024 | Clearpath, Ahmed Glaucoma Valve, Kahook Dual Blade |
| Eyevance Pharmaceuticals LLC | $12.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Oussama Boundaoui listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.